Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Treadmill Stress Testing

  • Author: David Akinpelu, MD, FACP; Chief Editor: Eric H Yang, MD  more...
 
Updated: Nov 22, 2015
 

Background

Exercise testing is a cardiovascular stress test that uses treadmill bicycle exercise with electrocardiography (ECG) and blood pressure monitoring.[1]  Pharmacologic stress testing, established after exercise testing, is a diagnostic procedure in which cardiovascular stress induced by pharmacologic agents is demonstrated in patients with decreased functional capacity or in patients who cannot exercise. Pharmacologic stress testing is used in combination with imaging modalities such as radionuclide imaging and echocardiography.[2, 3]

Exercise stress testing, which is now widely available at a relatively low cost, is currently used most frequently to estimate prognosis and determine functional capacity, to assess the probability and extent of coronary disease, and to assess the effects of therapy. Ancillary techniques, such as metabolic gas analysis, radionuclide imaging (see the images below), and echocardiography, can provide further information that may be needed in selected patients, such as those with moderate or prior risk.

Normal radionuclide uptake (dipyridamole-Cardiolit Normal radionuclide uptake (dipyridamole-Cardiolite).
Normal wall motion with radionuclide uptake. Normal wall motion with radionuclide uptake.

Cardiovascular exercise stress testing in conjunction with ECG has been established as one of the focal points in the diagnosis and prognosis of cardiovascular disease, specifically coronary artery disease (CAD).[4, 5]  Findings from the Henry Ford Exercse Testing (FIT) Project appear to indicate a graded, inverse relationship between cardiorespiratory fitness and incident atrial fibrillation, particularly for obese patients.[6]

Exercise physiology

The initiation of dynamic exercise results in increases in ventricular heart rate, stroke volume, and cardiac output as a result of vagal withdrawal and sympathetic stimulation. Alveolar ventilation and venous return also increase as a consequence of sympathetic vasoconstriction. The overall hemodynamic response depends on the amount of muscle mass involved, exercise efficiency, conditioning, and exercise intensity.

In the initial phases of exercise in the upright position, cardiac output is increased by an augmentation in stroke volume mediated through the use of the Frank-Starling mechanism and heart rate. The increase in cardiac output in the later phases of exercise is due primarily to an increase in ventricular rate.

During strenuous exertion, sympathetic discharge is maximal and parasympathetic stimulation is withdrawn, resulting in autoregulation with generalized vasoconstriction, except in the vital organs (cerebral and coronary circulations).

Release of venous and arterial norepinephrine from sympathetic postganglionic nerve endings is increased, and epinephrine levels are increased at peak exertion, resulting in a rise in ventricular contractility. As exercise progresses, skeletal muscle blood flow increases; oxygen extraction increases as much as 3-fold; peripheral resistance decreases; and systolic blood pressure (SBP), mean arterial pressure, and pulse pressure usually increase. Diastolic blood pressure (DBP) remains unchanged or may increase or decrease by approximately 10 mm Hg.

The pulmonary vascular bed can accommodate as much as a 6-fold increase in cardiac output, with only modest increases in pulmonary arterial pressure, pulmonary capillary wedge pressure, and right atrial pressure; this is not a limiting determinant of peak exercise capacity in healthy subjects.

Maximum heart rate and cardiac output are decreased in older individuals, in part because of decreased beta-adrenergic responsiveness. Maximum heart rate can be calculated by subtracting the patient’s age (in years) from 220 (standard deviation, 10-12 beats/min).

The age-predicted maximum heart rate is a useful measurement for safety purposes and for estimating the adequacy of the stress to evoke inducible ischemia. A patient who reaches 80% of the age-predicted maximum is considered to have a good test result, and an age-predicted maximum of 90% or better is considered excellent.

In the postexercise phase, hemodynamics return to baseline within minutes after exercise is discontinued. The return of vagal stimulation is an important cardiac deceleration mechanism after exercise; it is more pronounced in well-trained athletes but is blunted in patients with chronic congestive heart failure.

Intense physical work or important cardiorespiratory impairment may interfere with achievement of a steady state, and an oxygen deficit occurs during exercise. The oxygen debt is the total oxygen uptake in excess of the resting oxygen uptake during the recovery period.

Next

Indications and Contraindications

Treadmill stress testing is indicated for diagnosis and prognosis of cardiovascular disease, specifically CAD. This is the initial procedure of choice in patients with a normal or near-normal resting electrocardiogram who are capable of adequate exercise.[7]  Contraindications have been outlined in guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA).

Absolute contraindications include the following:

  • Acute myocardial infarction (MI; within 2 days)
  • Unstable angina not previously stabilized by medical therapy – Appropriate timing of tests depends on the level of risk of unstable angina as defined by the Agency for Health Care Policy and Research Unstable Angina Guidelines
  • Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise
  • Symptomatic severe aortic stenosis
  • Uncontrolled symptomatic heart failure
  • Acute pulmonary embolus or pulmonary infarction
  • Acute myocarditis or pericarditis
  • Acute aortic dissection

Relative contraindications can be superseded if the benefits of exercise outweigh the risks. They include the following:

  • Left main coronary stenosis
  • Moderate stenotic valvular heart disease
  • Electrolyte abnormalities
  • Severe arterial hypertension – In the absence of definite evidence, the committee suggests an SBP higher than 200 mm Hg, a DBP higher than 110 mm Hg, or both
  • Tachyarrhythmias or bradyarrhythmias
  • Hypertrophic cardiomyopathy and any other forms of outflow tract obstruction
  • Mental or physical impairment leading to an inability to exercise adequately

The vast majority of treadmill exercise tests are performed on adults with symptoms of known or probable ischemic heart disease. Candidates for exercise stress testing may have stable symptoms of chest pain, may be stabilized by medical therapy after experiencing symptoms of unstable chest pain, or may have already had an MI or undergone a vascularization procedure.

For patients with prior revascularization, uninterpretable electrocardiograms, or inability to adequately exercise, stress imaging is recommended.[7]

The clinical suggestion of CAD on the basis of patient history findings, ECG tracings, and symptoms of chest pain must be established and used as a guide to determine if treadmill exercise testing may be useful according to the Bayes theorem, which states that the diagnostic power of exercise stress testing is maximal when the pretest probability of CAD is intermediate (30-70%) as indicated by age, sex, and nature of chest pain.

When the diagnosis of CAD is confirmed on the basis of age, sex, description of chest pain, and history of previous MI, a clinical need may arise for risk or prognostic assessment to reach a decision regarding possible coronary angiography or revascularization to guide further medical management.

MI (see the images below) is a common first presentation of ischemic heart disease. This subset of patients also may require prognostic or risk assessment.

Inferior-wall myocardial infarct and fixed defect. Inferior-wall myocardial infarct and fixed defect.
Motion abnormalities in inferior wall consistent w Motion abnormalities in inferior wall consistent with inferior-wall myocardial infarction.
Inferobasal fixed defect and lateral wall ischemia Inferobasal fixed defect and lateral wall ischemia.
Wall motion abnormalities in inferobasal region. Wall motion abnormalities in inferobasal region.
Previous
Next

Technical Considerations

Best practices

The ACC/AHA guidelines for exercise stress testing were initially developed in 1997 to create recommendations for the appropriate use of testing in the diagnosis, prognosis, and treatment of patients with known or probable cardiovascular disease.[8] These guidelines were revised in 2002.[9]

In the original guidelines, the available scientific evidence was not ranked as belonging to level A, B, or C. In the later recommendations that appear in the update, however, the level of evidence is considered.

Evidence is ranked highest (A) if the data are based on multiple randomized clinical trials involving large numbers of patients. An intermediate rank (B) indicates data derived from a limited number of randomized trials involving small numbers of patients or from careful analyses of nonrandomized studies or observational registries. The lowest rank (C) indicates that the recommendation is primarily based on expert consensus. When few or no data exist, this is noted in the text.

ACC/AHA classes I, II, and III are used to categorize indications for exercise stress testing; they include the following:

  • Class I – Conditions for which evidence and/or general agreement exists that a given procedure or treatment is useful and effective
  • Class II – Conditions for which conflicting evidence and/or a divergence of opinion exists concerning the usefulness or efficacy of a procedure or treatment; this class is further divided into subclasses IIa and IIb
  • Class IIa – The weight of evidence/opinion is in favor of usefulness/efficacy
  • Class IIb – Usefulness/efficacy is less well established by evidence/opinion
  • Class III – Conditions for which evidence and/or general agreement exists that the procedure/treatment is not useful/effective and, in some cases, may be harmful

Complication prevention

Exercise testing is a well-established procedure that has been in widespread clinical use for decades. Although it is generally safe, both myocardial infarction and death have been reported and can be expected to occur at a rate of 1 incident per 2500 tests. Therefore, it is vital to use good clinical judgment when deciding which patients should undergo exercise testing.

Factors that are important in establishing good clinical outcomes from exercise testing include the following:

  • The quality, expertise, and experience of the professional and technical staff performing and interpreting the study (to reduce observer error)
  • The sensitivity, specificity, and accuracy of the technique (to establish limitations of this procedure)
  • The cost and accuracy of the technique as compared with more expensive imaging procedures (to establish the risk-to-benefit ratio, to determine the effect of positive or negative results on clinical decision making, and, to weigh the potential psychological benefits of patient reassurance)
Previous
 
 
Contributor Information and Disclosures
Author

David Akinpelu, MD, FACP Emergency Medicine Attending Physician, Riverside Tappahannock Hospital/Riverside Shore Memorial Hospital, Riverside Medical Group

David Akinpelu, MD, FACP is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine, American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Eric H Yang, MD Associate Professor of Medicine, Director of Cardiac Catherization Laboratory and Interventional Cardiology, Mayo Clinic Arizona

Eric H Yang, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

Acknowledgements

Javier M Gonzalez, MD Consulting Staff, Department of Cardiology, Citrus Cardiology Consultants

Javier M Gonzalez, MD is a member of the following medical societies: American College of Cardiology and American Medical Association

Disclosure: Nothing to disclose.

Ronald J Oudiz, MD, FACP, FACC, FCCP Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, LA Biomedical Research Institute at Harbor-UCLA Medical Center

Ronald J Oudiz, MD, FACP, FACC, FCCP is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Heart Association, and American Thoracic Society

Disclosure: Actelion Grant/research funds Clinical Trials + honoraria; Encysive Grant/research funds Clinical Trials + honoraria; Gilead Grant/research funds Clinical Trials + honoraria; Pfizer Grant/research funds Clinical Trials + honoraria; United Therapeutics Grant/research funds Clinical Trials + honoraria; Lilly Grant/research funds Clinical Trials + honoraria; LungRx Clinical Trials + honoraria; Bayer Grant/research funds Consulting

Justin D Pearlman, MD, ME, PhD, FACC, MA Chief, Division of Cardiology, Director of Cardiology Consultative Service, Director of Cardiology Clinic Service, Director of Cardiology Non-Invasive Laboratory, Director of Cardiology Quality Program KMC, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School

Justin D Pearlman, MD, ME, PhD, FACC, MA is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Federation for Medical Research, International Society for Magnetic Resonance in Medicine, and Radiological Society of North America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Libby P, Bonow RO, Mann DL, Zipes DP. Exercise stress testing. Braunwald E, ed. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa: WB Saunders; 2007.

  2. Botvinick EH. Current methods of pharmacologic stress testing and the potential advantages of new agents. J Nucl Med Technol. 2009 Mar. 37(1):14-25. [Medline].

  3. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging. 2008 May. 1(3):307-16. [Medline].

  4. Feil H, Seigel ML. Electrocardiographic changes during attacks of angina pectoris. Am J Med Sci. 1928. 175:255.

  5. Master AM, Oppenheimer ET. A simple exercise tolerance test for circulatory efficiency with standard tables for normal individuals. Am J Med Sci. 1929. 177:223.

  6. Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015 May 26. 131 (21):1827-34. [Medline].

  7. Miller TD, Askew JW, Anavekar NS. Noninvasive stress testing for coronary artery disease. Heart Fail Clin. 2016 Jan. 12 (1):65-82. [Medline].

  8. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997 Jul. 30(1):260-311. [Medline].

  9. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002 Oct 16. 40(8):1531-40. [Medline].

  10. Weintraub WS, Madeira SW Jr, Bodenheimer MM, et al. Critical analysis of the application of Bayes' theorem to sequential testing in the noninvasive diagnosis of coronary artery disease. Am J Cardiol. 1984 Jul 1. 54(1):43-9. [Medline].

  11. Michaelides AP, Psomadaki ZD, Dilaveris PE, et al. Improved detection of coronary artery disease by exercise electrocardiography with the use of right precordial leads. N Engl J Med. 1999 Feb 4. 340(5):340-5. [Medline].

  12. Morise AP. Accuracy of heart rate-adjusted ST segments in populations with and without posttest referral bias. Am Heart J. 1997 Oct. 134(4):647-55. [Medline].

  13. Okin PM, Kligfield P. Heart rate adjustment of ST segment depression and performance of the exercise electrocardiogram: a critical evaluation. J Am Coll Cardiol. 1995 Jun. 25(7):1726-35. [Medline].

  14. Viik J, Lehtinen R, Malmivuo J. Detection of coronary artery disease using maximum value of ST/HR hysteresis over different number of leads. J Electrocardiol. 1999. 32 Suppl:70-5. [Medline].

  15. Froelicher VF, Lehmann KG, Thomas R, et al. The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Veterans Affairs Cooperative Study in Health Services #016 (QUEXTA) Study Group. Quantitative Exercise Testing and Angiography. Ann Intern Med. 1998 Jun 15. 128(12 Pt 1):965-74. [Medline].

  16. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/NSTEMI: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/NSTEMI) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interve... J Am Coll Cardiol. 2007 Aug 14. 50(7):e1-e157. [Medline].

  17. Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 May 10. 123(18):e426-579. [Medline].

  18. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 May 10. 123(18):2022-60. [Medline].

  19. Lindahl B, Andren B, Ohlsson J, Venge P, Wallentin L. Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J. 1997 May. 18(5):762-70. [Medline].

  20. Zalenski RJ, Rydman RJ, Ting S, Kampe L, Selker HP. A national survey of emergency department chest pain centers in the United States. Am J Cardiol. 1998 Jun 1. 81(11):1305-9. [Medline].

  21. Gibler WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995 Jan. 25(1):1-8. [Medline].

  22. Farkouh ME, Smars PA, Reeder GS, et al. A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med. 1998 Dec 24. 339(26):1882-8. [Medline].

  23. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA. 1999 Feb 10. 281(6):524-9. [Medline].

  24. Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF, Mora S. Exercise blood pressure and future cardiovascular death in asymptomatic individuals. Circulation. 2010 May 18. 121(19):2109-16. [Medline].

  25. Shah BR, Cowper PA, O'Brien SM, et al. Association between physician billing and cardiac stress testing patterns following coronary revascularization. JAMA. 2011 Nov 9. 306(18):1993-2000. [Medline].

 
Previous
Next
 
Normal radionuclide uptake (dipyridamole-Cardiolite).
Normal wall motion with radionuclide uptake.
Inferior-wall myocardial infarct and fixed defect.
Motion abnormalities in inferior wall consistent with inferior-wall myocardial infarction.
Inferobasal fixed defect and lateral wall ischemia.
Wall motion abnormalities in inferobasal region.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.